Suchergebnisse - "Tubb, Vanessa"
-
1
Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies
ISSN: 2051-1426, 2051-1426Veröffentlicht: London BioMed Central 13.07.2018Veröffentlicht in Journal for immunotherapy of cancer (13.07.2018)“… Mutation-derived neoantigens represent an important class of tumour-specific, tumour rejection antigens, and are attractive targets for TCR gene therapy of …”
Volltext
Journal Article -
2
Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity
ISSN: 1528-0020, 1528-0020Veröffentlicht: United States 03.09.2020Veröffentlicht in Blood (03.09.2020)“… Hematological and solid cancers catabolize the semiessential amino acid arginine to drive cell proliferation. However, the resulting low arginine …”
Weitere Angaben
Journal Article -
3
The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated‐recombinant arginase I BCT‐100
ISSN: 0020-7136, 1097-0215, 1097-0215Veröffentlicht: United States Wiley Subscription Services, Inc 01.04.2018Veröffentlicht in International journal of cancer (01.04.2018)“… Arginine is a semi‐essential amino acid that plays a key role in cell survival and proliferation in normal and malignant cells. BCT‐100, a pegylated (PEG) …”
Volltext
Journal Article -
4
Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses
ISSN: 1540-9538, 1540-9538Veröffentlicht: United States 04.09.2023Veröffentlicht in The Journal of experimental medicine (04.09.2023)“… Mucosal-associated invariant T (MAIT) cells use canonical semi-invariant T cell receptors (TCR) to recognize microbial riboflavin precursors displayed by the …”
Weitere Angaben
Journal Article -
5
346 Pre-clinical characterization of AZD0240, a CRISPR-engineered autologous TCR-T cell product targeting KRAS-G12D/HLA-A11:01 that is multi-armored to increase epitope sensitivity
ISSN: 2051-1426Veröffentlicht: London BMJ Publishing Group LTD 01.11.2025Veröffentlicht in Journal for immunotherapy of cancer (01.11.2025)“… BackgroundKRAS is one of the most mutated genes in human cancer, with the G12D mutation having the highest frequency, occurring in 28% and 12% of pancreatic …”
Volltext
Journal Article -
6
The development of novel t cell receptor, and chimeric antigen receptor, engineered t cell therapies for the treatment of cancer
Veröffentlicht: ProQuest Dissertations & Theses 01.01.2017“… The ability to generate a tumour-reactive T cell compartment is possible through the genetic engineering of patient T cells with tumour-reactive TCRs or CARs …”
Volltext
Dissertation -
7
Project 1: the role of PTPN22.6 in intermediate uveitis and Project 2: cord blood mononuclear cells as an alternative source for chimeric antigen receptor-mediated cancer immunotherapy
Veröffentlicht: ProQuest Dissertations & Theses 01.01.2013“… Project 1. BACKGROUND: Uveitis, an inflammatory disease with a putative autoimmune component, is a major cause of visual impairment in the UK. Lyp is a protein …”
Volltext
Dissertation